Get the Stockscreener App
1.02
0.97%
-0.01
After Hours:
1.04
0.02
+1.96%
Lucid Diagnostics Inc stock is traded at $1.02, with a volume of 624.98K.
It is down -0.97% in the last 24 hours and down -11.30% over the past month.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
See More
Previous Close:
$1.03
Open:
$1.04
24h Volume:
624.98K
Relative Volume:
0.84
Market Cap:
$199.16M
Revenue:
$4.71M
Net Income/Loss:
$-58.01M
P/E Ratio:
-1.2388
EPS:
-0.8234
Net Cash Flow:
$-46.68M
1W Performance:
-6.42%
1M Performance:
-11.30%
6M Performance:
-1.92%
1Y Performance:
-9.73%
1-Day Range:
$1.02
$1.06
1-Week Range:
$1.02
$1.1198
52-Week Range:
$0.9495
$1.70
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Name
Lucid Diagnostics Inc
Sector
Industry
Phone
212 949 4319
Address
360 MADISON AVENUE, NEW YORK
Compare LUCD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.02 | 201.11M | 4.71M | -58.01M | -46.68M | -0.8234 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-27-21 | Initiated | Ascendiant Capital Markets | Buy |
| Nov-08-21 | Initiated | BTIG Research | Buy |
| Nov-08-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-08-21 | Initiated | Needham | Buy |
Lucid Diagnostics Inc Stock (LUCD) Latest News
Lucid Diagnostics Inc. (LUCD) may report negative earnings: Know the trend ahead of next week's release - MSN
Lucid Diagnostics Stock Price Forecast. Should You Buy LUCD? - StockInvest.us
Q3 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
Lucid Diagnostics Inc. (LUCD) reports Q4 loss, beats revenue estimates - MSN
PAVmed will outline Q1 results and strategy in a May 15 webcast - Stock Titan
Lucid Diagnostics (NASDAQ: LUCD) seeks big share increase in 2026 proxy - Stock Titan
Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026 - BioSpace
Lucid Diagnostics will detail Q1 results and strategy on May 14 - Stock Titan
Lucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIG - MSN
Lucid Diagnostics closes underwritten offering of common stock - Medical Buyer
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock - marketscreener.com
Lucid Diagnostics Raises Capital Through Direct Share Offering - The Globe and Mail
Lucid Diagnostics closes $18M stock offering at $1 per share - Investing.com Australia
Lucid Diagnostics (LUCD) CMO reports 650K restricted shares and 100K options - Stock Titan
Lucid Diagnostics closes $18M underwritten offering, issues 18M shares at $1.00 - TradingView
Lucid Diagnostics (NASDAQ: LUCD) closes $18M underwritten stock sale - Stock Titan
Lucid Diagnostics Closes $18 Million Share Offering - Intellectia AI
Lucid Diagnostics prices $18M stock offering at $1 per share - Investing.com India
Lucid Diagnostics Prices $18 Million Public Equity Offering - TipRanks
Lucid Diagnostics (LUCD) raises $18M with 18M-share offering (NASDAQ: LUCD) - Stock Titan
Lucid Diagnostics Prices $18 Million Underwritten Offering at $1 Per Share With Canaccord and BTIG - TradingView
Lucid Diagnostics (Nasdaq: LUCD) prices $18M underwritten stock sale - Stock Titan
Lucid Diagnostics prices 18M shares at $1.00 in registered direct offering - TipRanks
Lucid Diagnostics prices $18M stock offering at $1 per share By Investing.com - Investing.com South Africa
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock - PR Newswire
Lucid Diagnostics (LUCD) Annual Recap | Lucid Diagnostics posts 2% EPS beat, beats consensus loss estimatesDividend Cut Risk - Xã Vĩnh Công
Lucid Diagnostics (NASDAQ: LUCD) seeks 100M-share authorization increase - Stock Titan
Lucid Diagnostics (LUCD) Stock: Why It Matters Now (+3.20%) 2026-04-20Risk Management - Xã Vĩnh Công
Needham Reiterates Lucid Diagnostics (LUCD) Buy Recommendation - MSN
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Needham Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Maintains Target Price $3 - 富途牛牛
Victoria Tou Ho Lee Net Worth (2026) - GuruFocus
Lucid Diagnostics Outperforms Pressure BioSciences in Key Metrics - National Today
Lucid Diagnostics (LUCD) CMO holds 650K shares including restricted stock - Stock Titan
Layoff Watch: Whats the MACD signal for Lucid Diagnostics Inc2026 Analyst Calls & Long Hold Capital Preservation Plans - baoquankhu1.vn
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 - Quantisnow
Fed Meeting: Is Lucid Diagnostics Inc stock forming a cup and handle2026 PreEarnings & Community Consensus Picks - baoquankhu1.vn
Dividend Watch: Can Lucid Diagnostics Inc be recession proofTrade Exit Report & Precise Swing Trade Alerts - baoquankhu1.vn
Ascendiant Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Raises Target Price to $9 - Moomoo
Breakout Move: What is the next catalyst for Lucid Diagnostics Inc2026 Performance Recap & Daily Profit Maximizing Tips - baoquankhu1.vn
Lucid Diagnostics to Participate in Needham Healthcare Conference - National Today
Lucid Diagnostics to Participate in Fireside Chat at the 25th An - GuruFocus
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference - Bitget
Lucid Diagnostics to Participate in Fireside Chat at Healthcare Conference - National Today
Lucid Diagnostics CEO to Participate in Healthcare Conference - Intellectia AI
Lucid Diagnostics Inc. $LUCD Shares Purchased by Aberdeen Group plc - MarketBeat
Lucid Diagnostics Inc Stock (LUCD) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):